BioNTech makes Singapore its regional HQ to allow easy access to vaccines
Stay updated with the latest in Tech, Science, Culture, Entertainment, and more by following our Telegram channel here.
German biopharmaceutical company BioNTech (aka the other half of the Pfizer-BioNTech vaccine) has announced plans to build its new regional headquarters, along with an mRNA vaccine production facility, in Singapore.
In its press release, the firm stated that the new facility will allow Southeast Asia to stand on equal footing with other vaccine-producing players…
Post comments (0)